We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$23.7B
AUM Growth
+$1.26B
Cap. Flow
+$2.43B
Cap. Flow %
10.25%
Top 10 Hldgs %
31.04%
Holding
1,328
New
56
Increased
716
Reduced
259
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$229M
2
MSFT icon
Microsoft
MSFT
+$208M
3
NVDA icon
NVIDIA
NVDA
+$198M
4
AMZN icon
Amazon
AMZN
+$197M
5
NOW icon
ServiceNow
NOW
+$193M

Top Sells

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$173M
2
SPG icon
Simon Property Group
SPG
+$154M
3
WELL icon
Welltower
WELL
+$114M
4
AMT icon
American Tower
AMT
+$96.9M
5
ELS icon
Equity Lifestyle Properties
ELS
+$88M

Sector Composition

Rank Sector Weight
1 Real Estate 35.46%
2 Technology 23.73%
3 Communication Services 9.02%
4 Consumer Discretionary 6.33%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DFTX
1226
Definium Therapeutics
DFTX
$5.6B
$1K ﹤0.01%
242
– –
MRVI icon
1227
Maravai LifeSciences
MRVI
$972M
$1K ﹤0.01%
490
– –
MXCT icon
1228
MaxCyte
MXCT
$108M
$1K ﹤0.01%
293
– –
NMRA icon
1229
Neumora Therapeutics
NMRA
$306M
$1K ﹤0.01%
533
– –
OABI icon
1230
OmniAb
OABI
$283M
$1K ﹤0.01%
475
– –
OLMA icon
1231
Olema Pharmaceuticals
OLMA
$977M
$1K ﹤0.01%
224
– –
ORIC icon
1232
Oric Pharmaceuticals
ORIC
$1.17B
$1K ﹤0.01%
249
– –
PACB icon
1233
Pacific Biosciences
PACB
$435M
$1K ﹤0.01%
909
– –
PAHC icon
1234
Phibro Animal Health
PAHC
$1.5B
$1K ﹤0.01%
38
– –
PGEN icon
1235
Precigen
PGEN
$1.94B
$1K ﹤0.01%
708
– –
PRME icon
1236
Prime Medicine
PRME
$547M
$1K ﹤0.01%
398
– –
PSNL icon
1237
Personalis
PSNL
$1.25B
$1K ﹤0.01%
+400
New +$1.9K
RGNX icon
1238
Regenxbio
RGNX
$616M
$1K ﹤0.01%
146
– –
RIGL icon
1239
Rigel Pharmaceuticals
RIGL
$723M
$1K ﹤0.01%
+80
New +$1.62K
RLAY icon
1240
Relay Therapeutics
RLAY
$4B
$1K ﹤0.01%
486
– –
RNAC icon
1241
Cartesian Therapeutics
RNAC
$218M
$1K ﹤0.01%
84
– –
SANA icon
1242
Sana Biotechnology
SANA
$882M
$1K ﹤0.01%
767
– –
SIGA icon
1243
SIGA Technologies
SIGA
$240M
$1K ﹤0.01%
270
– –
SLDB icon
1244
Solid Biosciences
SLDB
$792M
$1K ﹤0.01%
+400
New +$1.71K
SLRN
1245
DELISTED
ACELYRIN
SLRN
$1K ﹤0.01%
398
– –
STOK icon
1246
Stoke Therapeutics
STOK
$1.84B
$1K ﹤0.01%
175
– –
THRD
1247
DELISTED
Third Harmonic Bio
THRD
$1K ﹤0.01%
149
– –
TRDA icon
1248
Entrada Therapeutics
TRDA
$254M
$1K ﹤0.01%
+150
New +$1.87K
TRML
1249
DELISTED
Tourmaline Bio
TRML
$1K ﹤0.01%
95
– –
TSHA icon
1250
Taysha Gene Therapies
TSHA
$1.61B
$1K ﹤0.01%
691
– –
48 49
50
51 52

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2025 Portfolio in Review

As of Q1 2025, Daiwa Securities Group held 1,328 positions worth $23.7B, up 5.6% from $22.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $2.43B of net new capital in Q1 2025, opening 56 new positions and adding to 716 existing holdings. Its largest new stake was Autoliv: 89,727 shares worth $7.94M.

By sector, the portfolio is most concentrated in Real Estate at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was VICI Properties, an estimated $173M trimmed.

  • Daiwa Securities Group's largest Q1 2025 buy was Autoliv: 89,727 shares worth $7.94M.
  • Daiwa Securities Group added most to Apple in Q1 2025, an estimated $229M increase.
  • Daiwa Securities Group's biggest Q1 2025 reduction was VICI Properties, cutting an estimated $173M.
  • Daiwa Securities Group fully exited Global X SuperDividend REIT ETF in Q1 2025, selling an estimated $20.8M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $23.7B portfolio in Q1 2025.
  • Daiwa Securities Group opened 56 new positions and closed 49 in Q1 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $23.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.